» Articles » PMID: 16403988

Anti-fibrosclerotic Effects of Shock Wave Therapy in Lipedema and Cellulite

Overview
Journal Biofactors
Publisher IOS Press
Specialty Biochemistry
Date 2006 Jan 13
PMID 16403988
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

In vivo measurements in 26 female patients with lipedema and cellulite parameters were carried out before and after therapy by means of complex physical decongestive therapy (CPDT) including manual lymph drainage and compression as main components and/or shock wave therapy (SWT). Oxidative stress parameters of blood serum and biomechanic skin properties/smoothening of dermis and hypodermis surface were evaluated. Oxidative stress in lipedema and cellulite was demonstrated by increased serum concentrations of malondialdehyde (MDA) and plasma protein carbonyls compared with healthy control persons. Both MDA and protein carbonyls in blood plasma decreased after serial shock wave application and CPDT. The SWT itself and CPDT itself lead to MDA release from edematous tissue into the plasma. Obviously both therapy types, SWT and CPDT, mitigate oxidative stress in lipedema and cellulite. In parallel SWT improved significantly the biomechanic skin properties leading to smoothening of dermis and hypodermis surface. Significant correlation between MDA depletion of edematous and lipid enriched dermis and improvement of mechanic skin properties was demonstrated. From these findings it is concluded, that a release of lipid peroxidation (LPO) products from edematous dermis is an important sclerosis-preventing effect of SWT and/or CPDT in lipedema and cellulite. Expression of factors stimulating angiogenesis and lymphangiogenesis such as VEGF was not induced by SWT and/or CPDT and, therefore, not involved in beneficial effects by SWT and/or CPDT.

Citing Articles

Lipedema: exploring pathophysiology and treatment strategies - state of the art.

Kamamoto F, Baiocchi J, Batista B, Ribeiro R, Modena D, Gornati V J Vasc Bras. 2025; 23():e20240025.

PMID: 39866170 PMC: 11758576. DOI: 10.1590/1677-5449.202400252.


Identification of Specific microRNAs in Adipose Tissue Affected by Lipedema.

Cione E, Michelini S, Abrego-Guandique D, Vaia N, Michelini S, Puleo V Curr Issues Mol Biol. 2024; 46(11):11957-11974.

PMID: 39590304 PMC: 11592672. DOI: 10.3390/cimb46110710.


Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema.

Vasella M, Wolf S, Francis E, Grieb G, Pfister P, Reid G Metabolites. 2023; 13(10).

PMID: 37887430 PMC: 10608777. DOI: 10.3390/metabo13101105.


Enhanced Angiogenesis in HUVECs Preconditioned with Media from Adipocytes Differentiated from Lipedema Adipose Stem Cells In Vitro.

Al-Ghadban S, Walczak S, Isern S, Martin E, Herbst K, Bunnell B Int J Mol Sci. 2023; 24(17).

PMID: 37686378 PMC: 10487727. DOI: 10.3390/ijms241713572.


Lipedema Research-Quo Vadis?.

Ernst A, Bauer H, Bauer H, Steiner M, Malfertheiner A, Lipp A J Pers Med. 2023; 13(1).

PMID: 36675759 PMC: 9860653. DOI: 10.3390/jpm13010098.